List view / Grid view

News

QbD in Pharma Development World Congress 2015

26 November 2014 | By SELECTBIO

SELECTBIO is organizing the 3rd Annual International QbD conference “QbD in Pharma Development World Congress 2015” with the theme "Emerging Challenges, Federal Issues & Possible Solutions" scheduled to be held on April 16-18, 2015 in Hotel Shivalik View, Chandigarh, India...

Promethera Biosciences raises €25.33 million ($31.4 million) in Series C financial round

25 November 2014 | By Promethera Biosciences

Promethera Biosciences, a Belgian biotechnology company developing Promethera® HepaStem, a cell-based therapy for the treatment of in-born errors of metabolism and acquired liver diseases, announces the completion of its Series C fundraising round. The company has raised €25.33 million ($31.4 million), including €20.33 million in capital...

Bioquell publishes case studies on the efficacy of its wound treatment solution

24 November 2014 | By Bioquell

The Bioquell wound treatment system, BioxyQuell, has been tested at a wound care clinic in Hampshire with patients suffering from long term chronic venous leg ulceration. The results, presented in two case studies, show how aqueous oxygen peroxide (AOP) applied using the BioxyQuell system reduced odours and pain as well…